CD86 and neoplasm: Both immunostimulatory CD8α + and CD8α- DC subsets were increased (Figure 2B), whereas expression of activation markers CD40, CD70, CD86, and of MHC Class I molecules in either subsets of tumor infiltrating DCs were not altered by CD1d blockade (Figure 2C-F).